Cargando…

Antigiardial activity of novel triazolyl-quinolone-based chalcone derivatives: when oxygen makes the difference

Giardiasis is a common diarrheal disease worldwide caused by the protozoan parasite Giardia intestinalis. It is urgent to develop novel drugs to treat giardiasis, due to increasing clinical resistance to the gold standard drug metronidazole (MTZ). New potential antiparasitic compounds are usually te...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahadur, Vijay, Mastronicola, Daniela, Singh, Amit K., Tiwari, Hemandra K., Pucillo, Leopoldo P., Sarti, Paolo, Singh, Brajendra K., Giuffrè, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389562/
https://www.ncbi.nlm.nih.gov/pubmed/25904901
http://dx.doi.org/10.3389/fmicb.2015.00256
_version_ 1782365588486619136
author Bahadur, Vijay
Mastronicola, Daniela
Singh, Amit K.
Tiwari, Hemandra K.
Pucillo, Leopoldo P.
Sarti, Paolo
Singh, Brajendra K.
Giuffrè, Alessandro
author_facet Bahadur, Vijay
Mastronicola, Daniela
Singh, Amit K.
Tiwari, Hemandra K.
Pucillo, Leopoldo P.
Sarti, Paolo
Singh, Brajendra K.
Giuffrè, Alessandro
author_sort Bahadur, Vijay
collection PubMed
description Giardiasis is a common diarrheal disease worldwide caused by the protozoan parasite Giardia intestinalis. It is urgent to develop novel drugs to treat giardiasis, due to increasing clinical resistance to the gold standard drug metronidazole (MTZ). New potential antiparasitic compounds are usually tested for their killing efficacy against G. intestinalis under anaerobic conditions, in which MTZ is maximally effective. On the other hand, though commonly regarded as an ‘anaerobic pathogen,’ G. intestinalis is exposed to relatively high O(2) levels in vivo, living attached to the mucosa of the proximal small intestine. It is thus important to test the effect of O(2) when searching for novel potential antigiardial agents, as outlined in a previous study [Bahadur et al. (2014) Antimicrob. Agents Chemother. 58, 543]. Here, 45 novel chalcone derivatives with triazolyl-quinolone scaffold were synthesized, purified, and characterized by high resolution mass spectrometry, (1)H and (13)C nuclear magnetic resonance and infrared spectroscopy. Efficacy of the compounds against G. intestinalis trophozoites was tested under both anaerobic and microaerobic conditions, and selectivity was assessed in a counter-screen on human epithelial colorectal adenocarcinoma cells. MTZ was used as a positive control in the assays. All the tested compounds proved to be more effective against the parasite in the presence of O(2), with the exception of MTZ that was less effective. Under anaerobiosis eighteen compounds were found to be as effective as MTZ or more (up to three to fourfold); the same compounds proved to be up to >100-fold more effective than MTZ under microaerobic conditions. Four of them represent potential candidates for the design of novel antigiardial drugs, being highly selective against Giardia trophozoites. This study further underlines the importance of taking O(2) into account when testing novel potential antigiardial compounds.
format Online
Article
Text
id pubmed-4389562
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-43895622015-04-22 Antigiardial activity of novel triazolyl-quinolone-based chalcone derivatives: when oxygen makes the difference Bahadur, Vijay Mastronicola, Daniela Singh, Amit K. Tiwari, Hemandra K. Pucillo, Leopoldo P. Sarti, Paolo Singh, Brajendra K. Giuffrè, Alessandro Front Microbiol Microbiology Giardiasis is a common diarrheal disease worldwide caused by the protozoan parasite Giardia intestinalis. It is urgent to develop novel drugs to treat giardiasis, due to increasing clinical resistance to the gold standard drug metronidazole (MTZ). New potential antiparasitic compounds are usually tested for their killing efficacy against G. intestinalis under anaerobic conditions, in which MTZ is maximally effective. On the other hand, though commonly regarded as an ‘anaerobic pathogen,’ G. intestinalis is exposed to relatively high O(2) levels in vivo, living attached to the mucosa of the proximal small intestine. It is thus important to test the effect of O(2) when searching for novel potential antigiardial agents, as outlined in a previous study [Bahadur et al. (2014) Antimicrob. Agents Chemother. 58, 543]. Here, 45 novel chalcone derivatives with triazolyl-quinolone scaffold were synthesized, purified, and characterized by high resolution mass spectrometry, (1)H and (13)C nuclear magnetic resonance and infrared spectroscopy. Efficacy of the compounds against G. intestinalis trophozoites was tested under both anaerobic and microaerobic conditions, and selectivity was assessed in a counter-screen on human epithelial colorectal adenocarcinoma cells. MTZ was used as a positive control in the assays. All the tested compounds proved to be more effective against the parasite in the presence of O(2), with the exception of MTZ that was less effective. Under anaerobiosis eighteen compounds were found to be as effective as MTZ or more (up to three to fourfold); the same compounds proved to be up to >100-fold more effective than MTZ under microaerobic conditions. Four of them represent potential candidates for the design of novel antigiardial drugs, being highly selective against Giardia trophozoites. This study further underlines the importance of taking O(2) into account when testing novel potential antigiardial compounds. Frontiers Media S.A. 2015-04-08 /pmc/articles/PMC4389562/ /pubmed/25904901 http://dx.doi.org/10.3389/fmicb.2015.00256 Text en Copyright © 2015 Bahadur, Mastronicola, Singh, Tiwari, Pucillo, Sarti, Singh and Giuffrè. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Bahadur, Vijay
Mastronicola, Daniela
Singh, Amit K.
Tiwari, Hemandra K.
Pucillo, Leopoldo P.
Sarti, Paolo
Singh, Brajendra K.
Giuffrè, Alessandro
Antigiardial activity of novel triazolyl-quinolone-based chalcone derivatives: when oxygen makes the difference
title Antigiardial activity of novel triazolyl-quinolone-based chalcone derivatives: when oxygen makes the difference
title_full Antigiardial activity of novel triazolyl-quinolone-based chalcone derivatives: when oxygen makes the difference
title_fullStr Antigiardial activity of novel triazolyl-quinolone-based chalcone derivatives: when oxygen makes the difference
title_full_unstemmed Antigiardial activity of novel triazolyl-quinolone-based chalcone derivatives: when oxygen makes the difference
title_short Antigiardial activity of novel triazolyl-quinolone-based chalcone derivatives: when oxygen makes the difference
title_sort antigiardial activity of novel triazolyl-quinolone-based chalcone derivatives: when oxygen makes the difference
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389562/
https://www.ncbi.nlm.nih.gov/pubmed/25904901
http://dx.doi.org/10.3389/fmicb.2015.00256
work_keys_str_mv AT bahadurvijay antigiardialactivityofnoveltriazolylquinolonebasedchalconederivativeswhenoxygenmakesthedifference
AT mastronicoladaniela antigiardialactivityofnoveltriazolylquinolonebasedchalconederivativeswhenoxygenmakesthedifference
AT singhamitk antigiardialactivityofnoveltriazolylquinolonebasedchalconederivativeswhenoxygenmakesthedifference
AT tiwarihemandrak antigiardialactivityofnoveltriazolylquinolonebasedchalconederivativeswhenoxygenmakesthedifference
AT pucilloleopoldop antigiardialactivityofnoveltriazolylquinolonebasedchalconederivativeswhenoxygenmakesthedifference
AT sartipaolo antigiardialactivityofnoveltriazolylquinolonebasedchalconederivativeswhenoxygenmakesthedifference
AT singhbrajendrak antigiardialactivityofnoveltriazolylquinolonebasedchalconederivativeswhenoxygenmakesthedifference
AT giuffrealessandro antigiardialactivityofnoveltriazolylquinolonebasedchalconederivativeswhenoxygenmakesthedifference